"Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention.

The Journal of invasive cardiology

Volumn 19, Issue 2, 2007, Pages 58-62

  Fischell, Tim A ^a   Subraya, Raviprasad G ^a   Ashraf, Kamal ^a   Perry, Benjamin ^a   Haller, Scott ^a  

^a Borgess Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICARDIPINE; VASODILATOR AGENT;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; COST BENEFIT ANALYSIS; DRUG EFFECT; ECONOMICS; ELECTROCARDIOGRAPHY; FEMALE; GRAFT OCCLUSION; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; SAPHENOUS VEIN; STENT; TRANSPLANTATION; TREATMENT OUTCOME; VASODILATATION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY VESSELS; COST-BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; GRAFT OCCLUSION, VASCULAR; HEART CATHETERIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; NICARDIPINE; REGIONAL BLOOD FLOW; SAPHENOUS VEIN; STENTS; TREATMENT OUTCOME; VASODILATION; VASODILATOR AGENTS;

EID: 33847281556     PISSN: None     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (0)